Ten63 Therapeutics
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Ten63 Therapeutics is currently valued at N/A as of January 10, 2025. The company has raised a total of $21.3M in funding.
Investment Perspective
Ten63 Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Ten63 Therapeutics Worth in 2025?
As of 2025, Ten63 Therapeutics is valued at N/A, based on the company's Later Stage VC funding round in January 10, 2025. This valuation positions Ten63 Therapeutics as one of the leading private companies in the sector.
Ten63 Therapeutics Valuation History
Ten63 Therapeutics's funding history demonstrates steady growth and investor confidence.
How Ten63 Therapeutics Valuation is Determined
Private company valuations like Ten63 Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Ten63 Therapeutics Valuation FAQs
Is Ten63 Therapeutics profitable?
Ten63 Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Ten63 Therapeutics's valuation compare to competitors?
Ten63 Therapeutics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Ten63 Therapeutics IPO?
Ten63 Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Ten63 Therapeutics shares through secondary market platforms.